Form 8-K/A Alexza Pharmaceuticals For: Mar 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
March 28, 2016 4:12 PM EDTAlexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.15), versus ($0.35) reported last year. Revenue for the quarter came in at $673 thousand, versus $1.45 million reported last year.
Alexza believes that, based on its cash and cash equivalent balances at December 31, 2015, the additional $1.0 million drawn... More



